(Press-News.org) Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible for smuggling the toxin of the bacterium Clostridium perfringens into the cell. The TpeL toxin, which is formed by C. perfringens, a pathogen that causes gas gangrene and food poisoning. It is very similar to the toxins of many other hospital germs of the genus Clostridium. The toxins bind to surface molecules and creep into the body cell, where they lead to cell death. "In order to prevent the toxin from entering the cell, it is necessary to find the receptor that serves as the gatekeeper. But the search for this key molecule remained unsuccessful for a long time," says Aktories, member of the Cluster of Excellence BIOSS Centre for Biological Signalling Studies. In cooperation with colleagues from Düsseldorf, the USA, and the Netherlands, the researchers from Freiburg have now identified a receptor for a clostridial toxin of this type for the first time ever. Their findings were published in the journal Proceedings of the National Academy of Sciences (PNAS).
Clostridia cause intestinal and wound diseases in humans and animals that are often fatal. "At the moment, infections with the bacterium Clostridium difficile are particularly problematic in hospitals. The diseases tend to appear following treatment with antibiotics and often lead to diarrhea, but also to fatal inflammations of the bowels," explains Aktories. The toxins force their way into host cells and deactivate signaling molecules by attaching a sugar molecule to these cellular switches. Once this signaling pathway has been switched off, the cell dies – infested tissue dies off.
In order to find the receptor, the researchers applied a genetic selection procedure, a so-called screening, in which individual genes in cells from human cancer cell lines are turned off at random. This procedure led to the discovery that cells are immune to the TpeL toxin when the gene for the protein LRP1 is switched off on the cell surface. LRP1, which stands for low density lipoprotein receptor-related protein 1, usually takes in proteins that serve as a means of transport for lipidsfats in the blood. The researchers demonstrate that LRP1 is the long sought-after key molecule: It also regulates the intake of the toxin TpeL.
His team also proposes a new model, explains Aktories: "Our findings indicate that two receptors are involved in the effect of the other sugar-carrying clostridial toxins." Researchers can use the findings to develop new agents against clostridia. "Our discovery will also provide new impetus for researchers to identify further toxin receptors," Aktories hopes.
INFORMATION:
Original publication:
Björn Schorch, Shuo Song, Ferdy R. van Diemen, Hans H. Bock, Petra May, Joachim Herz, Thijn R. Brummelkamp, Panagiotis Papatheodorou and Klaus Aktories
LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins.
PNAS 2014 ; published ahead of print April 15, 2014, doi:10.1073/pnas.1323790111
More Information on the BIOSS Centre for Biological Signalling Studies:
http://www.bioss.uni-freiburg.de/cms/index.php
Gate for bacterial toxins found
Freiburg researchers discover a molecule that smuggles toxins from intestinal pathogens into human cells
2014-04-16
ELSE PRESS RELEASES FROM THIS DATE:
Scientists explain how memories stick together
2014-04-16
LA JOLLA—Scientists at the Salk Institute have created a new model of memory that explains how neurons retain select memories a few hours after an event.
This new framework provides a more complete picture of how memory works, which can inform research into disorders liked Parkinson's, Alzheimer's, post-traumatic stress and learning disabilities.
"Previous models of memory were based on fast activity patterns," says Terry Sejnowski, holder of Salk's Francis Crick Chair and a Howard Hughes Medical Institute Investigator. "Our new model of memory makes it possible to ...
Shade grown coffee shrinking as a proportion of global coffee production
2014-04-16
The proportion of land used to cultivate shade grown coffee, relative to the total land area of coffee cultivation, has fallen by nearly 20 percent globally since 1996, according to a new study by scientists from The University of Texas at Austin and five other institutions.
The study's authors say the global shift toward a more intensive style of coffee farming is probably having a negative effect on the environment, communities and individual farmers.
"The paradox is that there is greater public interest than ever in environmentally friendly coffee, but where coffee ...
Synapses -- stability in transformation
2014-04-16
This news release is available in German. Synapses are the points of contact at which information is transmitted between neurons. Without them, we would not be able to form thoughts or remember things. For memories to endure, synapses sometimes have to remain stable for very long periods. But how can a synapse last if its components have to be replaced regularly? Scientists from the Max Planck Institute of Neurobiology in Martinsried near Munich have taken a decisive step towards answering this question. They have succeeded in demonstrating that when a synapse is formed, ...
Scratching the surface: Microbial etchings in impact glass and the search for life on Mars
2014-04-16
Boulder, Colo., USA – Haley M. Sapers and colleagues provide what may be the first report of biological activity preserved in impact glass. Recent research has suggested that impact events create novel within-rock microbial habitats. In their paper, "Enigmatic tubular features in impact glass," Sapers and colleagues analyze tubular features in hydrothermally altered impact glass from the Ries Impact Structure, Germany, that are remarkably similar to the bioalteration textures observed in volcanic glasses.
The authors note that mineral-forming processes cannot easily ...
Cancer drugs block dementia-linked brain inflammation, UCI study finds
2014-04-16
Irvine, Calif., April 16, 2014 — A class of drugs developed to treat immune-related conditions and cancer – including one currently in clinical trials for glioblastoma and other tumors – eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.
In their study, assistant professor of neurobiology & behavior Kim Green and colleagues discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including ...
Recycling industrial waste water
2014-04-16
A research group composed of Dr. Martin Prechtl, Leo Heim and their colleagues at the University of Cologne's Department of Chemistry has discovered a new method of generating hydrogen using water and formaldehyde. The generation of hydrogen from liquids is of particular interest when it comes to fuel cell technologies. The results of the project, entitled "Selective and mild hydrogen production using water and formaldehyde", have recently been published in the journal Nature Communications.
Among other applications, the new approach can be used to recycle industrial ...
Research uncovers DNA looping damage tied to HPV cancer
2014-04-16
It's long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might spark cancer development – by disrupting the human DNA sequence with repeating loops when the virus is inserted into host-cell DNA as it replicates.
Worldwide, HPV causes about 610,000 cases of cancer annually, accounting for about five percent of all cancer cases and virtually all cases of cervical cancer. Yet, the mechanisms behind the process aren't yet completely understood.
This study, recently ...
New type of barcode could make counterfeiters' lives more difficult
2014-04-16
Counterfeiters, beware! Scientists are reporting the development of a new type of inexpensive barcode that, when added to documents or currency, could foil attempts at making forgeries. Although the tags are easy for researchers to make, they still require ingredients you can't exactly find at the local hardware store. Their report appears in the Journal of the American Chemical Society.
Xiaogang Liu and colleagues explain that scientists have used fluorescent and DNA-based barcodes, or tags of known composition and sequence, in attempts to develop tests for cancer and ...
A greener source of polyester -- cork trees
2014-04-16
On the scale of earth-friendly materials, you'd be hard pressed to find two that are farther apart than polyester (not at all) and cork (very). In an unexpected twist, however, scientists are figuring out how to extract a natural, waterproof, antibacterial version of the first material from the latter. Their new technique, which could have applications in medical devices, appears in the ACS journal Biomacromolecules.
Cristina Silva Pereira and colleagues explain that polyesters are ubiquitous in modern life, and not just as a practical fabric for clothing. Their durability ...
Local homicide rate increases cause more elementary students to fail school
2014-04-16
WASHINGTON, DC, April 16, 2014 — A new study finds that an increase in a municipality's homicide rate causes more elementary school students in that community to fail a grade than would do so if the rate remained stable.
"This finding is a source of concern because exposure to environmental violence is highly prevalent in contemporary societies and is unequally distributed along socioeconomic lines," said study co-author Florencia Torche, an associate professor of sociology at New York University. "To the extent that children living in poverty are more likely to experience ...
LAST 30 PRESS RELEASES:
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
[Press-News.org] Gate for bacterial toxins foundFreiburg researchers discover a molecule that smuggles toxins from intestinal pathogens into human cells





